Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Gapping up $Rivian Automotive(RIVN.US)$+6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.) $Celsius Holdings(CELH.US)$+11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
Exact Sciences Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum $精密科学(EXAS.US)$Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum. Baird Upgrades Alcon to Outperform, Raises Price Target to $90 Baird analyst Jeff Johnson upgrades$Alcon(ALC.US)$from Neutral to Outperform and raises the price target from $75 to $90. BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125 B o...
Jefferies Downgraded to Market Perform From Outperform at Keefe Bruyette Keefe Bruyette analyst Michael Brown downgraded$杰富瑞(JEF.US)$to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note. Coupa Softwa...
Alcon股票讨论区
2023Q1营收增长7.5%,营业利润增长8.9%,净利润增长3.6%。
目前119.5倍市盈率看起来相当离谱。
专栏Today's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More
$Rivian Automotive(RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
专栏US Top Rating Updates on 5/10: PYPL, EXAS, CELH, GTLB and More
$精密科学(EXAS.US)$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $Alcon(ALC.US)$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...
专栏US Top Gap Ups and Downs on 5/3: AMD, VOD, SBUX, EL and More
Gap Ups
1. $尤纳姆集团(UNM.US)$ - up 5.1%
2. $Generac(GNRC.US)$ - up 5.0%
3. $Builders FirstSource(BLDR.US)$ - up 4.9%
4. $Livent(LTHM.US)$ - up 4.4%
5. $培生(PSO.US)$ - up 4.1%
6. $Verisk分析(VRSK.US)$ - up 3.6%
7. $安信龙保险(AIZ.US)$ - up 2.7%
8. $沃达丰(VOD.US)$ - up...
AKO Capital:
专栏US Top Gap Ups and Downs on 4/21: SAP, PG, NVO, WRB and More
Gap Ups
1. $SAP SE(SAP.US)$ - up 3.2%
2. $费森尤斯医疗(FMS.US)$ - up 3.1%
3. $HCA医疗(HCA.US)$ - up 2.2%
4. $宝洁(PG.US)$ - up 2.1%
5. $诺和诺德(NVO.US)$ - up 1.5%
6. $Alcon(ALC.US)$ - up 1.2%
7. $CyberArk(CYBR.US)$ - up 1.0%
8. $阿卡迪亚医疗保健(ACHC.US)$ - up 0.9%...
专栏US Top Gap Ups and Downs on 4/10: MU, WDC, BIDU, UMC and More
Gap Ups
1. $先锋自然资源(PXD.US)$ - up 4.1%
2. $美光科技(MU.US)$ - up 3.1%
3. $西部数据(WDC.US)$ - up 3.0%
4. $SiteOne Landscape Supply(SITE.US)$ - up 1.1%
5. $EQT能源(EQT.US)$ - up 0.7%
6. $美国网存(NTAP.US)$ - up 0.6%
7. $中华电信(CHT.US)$ - up 0.3%...
专栏US Top Gap Ups and Downs on 3/30: PHG, JD, OSH, LOGI and More
Gap Ups
1. $飞利浦(PHG.US)$ - up 4.5%
2. $Oak Street Health(OSH.US)$ - up 4.3%
3. $京东(JD.US)$ - up 3.7%
4. $AngloGold Ashanti(AU.US)$ - up 3.2%
5. $Alcon(ALC.US)$ - up 3.0%
6. $必和必拓(BHP.US)$ - up 2.6%
7. $爱立信(ERIC.US)$ - up 2.5%
8. $Paycom Software(PAYC.US)$ - up 2.1%...
专栏US Top Rating Updates on 12/22: JEF, COUP, BSX, COO and More
Keefe Bruyette analyst Michael Brown downgraded $杰富瑞(JEF.US)$ to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note.
Coupa Softwa...
暂无评论